---
layout: archive
title: "Publications"
permalink: /publications/
author_profile: true
---


You can also find a complete list of my articles on my [google scholar](https://scholar.google.com/citations?user=QTRX6BgAAAAJ&hl=en&oi=sra) profile.


A list of papers grouped by topic, with links to relevant data and **R** code, is provided below.


Heterogeneity of Treatment Effect
======

1. Segal, J.B., Varadhan, R., Groenwold, R.H.H., Henderson, N.C.,..., and M. Burcu (2023). [Assessing Heterogeneity of Treatment Effect in Real-World Data.](https://www.acpjournals.org/doi/abs/10.7326/M22-1510) *Annals of Internal Medicine*, **176**(4), 536-544.

2. Henderson, N.C., Louis, T.A., Rosner, G.L., and R. Varadhan (2020). [Individualized Treatment Effects with Censored Data via Fully Nonparametric Bayesian Accelerated Failure Time Models.](https://academic.oup.com/biostatistics/article/21/1/50/5056258) *Biostatistics*, **21**, 50-68.

3. Lesko, C.R., Henderson, N.C., and R. Varadhan (2018). [Considerations when Assessing Heterogeneity of Treatment Effect in Patient-Centered Outcomes Research.](https://www.sciencedirect.com/science/article/abs/pii/S0895435617301099) *Journal of Clinical Epidemiology*, **100**, 22-31. 

4. Henderson, N.C. and R. Varadhan (2018). [Bayesian Bivariate Subgroup Analysis for Risk-Benefit Evaluation.](https://link.springer.com/article/10.1007/s10742-018-0188-1) *Health Services and Outcomes Research Methodology*, **18**(4), 244-264.

5. Wang, C., Louis, T.A., Henderson, N.C., Weiss, C.O., and R. Varadhan (2018). [BEANZ: A Web-based Software for Bayesian Analysis of Heterogeneous Treatment Effect in Patient-Centered Outcomes Research.](https://www.jstatsoft.org/article/view/v085i07) *Journal of Statistical Software*, **85**(7), 1-31.

6. Henderson, N.C., Louis, T.A., Wang, C., and R. Varadhan (2016). [Bayesian Analysis of Heterogeneous Treatment Effects for Patient-Centered Outcomes Research.](https://link.springer.com/article/10.1007/s10742-016-0159-3) *Health Services and Outcomes Research Methodology*, **16**(4), 213-233.

7. Ashouri, M., and N.C. Henderson (2025). [Evaluating and Testing for Actionable Treatment Effect Heterogeneity](https://arxiv.org/abs/2503.04093) ArXiv preprint.

Survival Analysis and Bayesian Additive Regression Trees (BART)
======

1. Henderson, N.C., Nam, K., and D. Feng (2024). [Nonparametric Analysis of Delayed Treatment Effects using Single-Crossing Constraints.](https://onlinelibrary.wiley.com/doi/full/10.1002/bimj.202200165) *Biometrical Journal*, **66**(2), 2200165.

2. Henderson, N.C., Louis, T.A., Rosner, G.L., and R. Varadhan (2020). [Individualized Treatment Effects with Censored Data via Fully Nonparametric Bayesian Accelerated Failure Time Models.](https://academic.oup.com/biostatistics/article/21/1/50/5056258) *Biostatistics*, **21**, 50-68.

3. Ashouri, M. and N.C. Henderson. [Generalized Bayesian Additive Regression Trees for Restricted Mean Survival Time Inference.](https://arxiv.org/abs/2402.17920) ArXiv preprint


Empirical Bayes/Shrinkage Estimation
======

1. Henderson, N.C., Varadhan, R., and T. A. Louis (2023). [Improved Small Domain Estimation via Compromise Regression Weights.](https://www.tandfonline.com/doi/abs/10.1080/01621459.2022.2080682) *Journal of the American Statistical Association*, **18**(544), 2793-2809.

2. Henderson, N.C. and M.A. Newton (2016). [Making the Cut: Improved Ranking and Selection for Large-Scale Inference.](https://academic.oup.com/jrsssb/article/78/4/781/7040692) *Journal of the Royal Statistical Society, Series B*, **78**, 781-804.




Data Integration/Real-World Evidence
======

1. Bhattacharyya, R., Henderson, N.C., and V. Baladandayuthapani (2024). [Functional Integrative Bayesian Analysis of High-dimensional Multiplatform Genomic Data.](https://www.tandfonline.com/doi/full/10.1080/01621459.2024.2388909)*Journal of the American Statistical Association*, **119**(548), 2533-2547..

2. Bhattacharyya, R. Henderson, N., and V. Baladandayuthapani (2023). [BaySyn: Bayesian Evidence Synthesis for Multi-system Multiomic Integration.](https://www.worldscientific.com/doi/abs/10.1142/9789811270611_0026) In *PACIFIC SYMPOSIUM ON BIOCOMPUTING 2023: Proceedings of the Pacific Symposium*, 275 - 286.

3. Nam, K., Henderson, N.C., Rohan, P., and E. Russek-Cohen (2021). [Penalized Logistic Regression Likelihood Ratio Test Analysis to Detect Signals of Adverse Events from Interactions in Postmarket Safety Surveillance.](https://www.tandfonline.com/doi/abs/10.1080/19466315.2020.1752299) *Statistics in Biopharmaceutical Research*, **13**(4), 405-414.

4. Henderson, N.C., Varadhan, R., and C. O. Weiss (2017). [Cross-Design Synthesis for Extending the Applicability of Trial Evidence when Treatment Effect is Heterogeneous: Part II. Application and External Validation.](https://www.tandfonline.com/doi/abs/10.1080/23737484.2017.1398056)
*Communications in Statistics: Case Studies, Data Analysis and Applications*, **3**, 7-20.

5. Nam, K., Henderson, N.C., Rohan, P., E.J. Woo, and E. Russek-Cohen (2017). [Logistic Regression Likelihood Ratio Test Analysis for Detecting Signals of Vaccine Adverse Events in Vaccine Safety Surveillance.](https://www.tandfonline.com/doi/abs/10.1080/10543406.2017.1295250) *Journal of Biopharmaceutical Statistics*, **27**, 990-1008.

6. Varadhan, R., Henderson, N.C., and C. O. Weiss (2016). [Cross-Design Synthesis for Extending the Applicability of Trial Evidence when Treatment Effect is Heterogeneous: Part I. Methodology.](https://www.tandfonline.com/doi/abs/10.1080/23737484.2017.1392265)
*Communications in Statistics: Case Studies, Data Analysis and Applications*, **2**, 112-126.




Computational Statistics
======

1. Henderson, N.C. and Z. Ouyang. [Parameter-expanded ECME algorithms for Logistic and Penalized Logistic Regression.](https://arxiv.org/abs/2304.03904) To appear in Computational Statistics.

2. Tang, B., Henderson, N.C., and R. Varadhan (2023). [Accelerating Fixed-Point Algorithms in Statistics and Data Science: A State-of-Art Review.](https://jds-online.org/journal/JDS/article/1288/info) *Journal of Data Science*, **21**(1), 1-26.

3. Henderson, N.C. and R. Varadhan (2019). [Damped Anderson Acceleration with Restarts and Monotonicity Control for Accelerating EM and EM-like Algorithms.](https://www.tandfonline.com/doi/abs/10.1080/10618600.2019.1594835) *Journal of Computational and Graphical Statistics*, **28**(4), 834-846.

4. Henderson, N.C. and P.J. Rathouz (2018). [AR(1) Latent Class Models for Longitudinal Count Data.](https://onlinelibrary.wiley.com/doi/abs/10.1002/sim.7931) *Statistics in Medicine*, **37**, 4441-4456.

5. McDaniel, L.S., Henderson, N.C., and P.J. Rathouz (2013). [Fast Pure R Implementation of GEE: Application of the Matrix Package.](https://journal.r-project.org/archive/2013-1/mcdaniel-henderson-rathouz.pdf) *The R Journal*, **5**(1), 181-188.




# Cancer Applications

## Prostate Cancer

1. Zengin, Z.B., Henderson, N.C., Park, J.J., ..., and T. Dorff (2024). [Clinical implications of AR alterations in advanced prostate cancer: a multi-institutional collaboration.](https://www.nature.com/articles/s41391-024-00805-3) *Prostate Cancer and Prostatic Diseases*.

2. Hwang, C., Henderson, N.C., Cackowski, F.C., ..., and P. Barata (2023). [Biomarker-directed Therapy in Black and White Men with Metastatic Castration-resistant Prostate Cancer (mCRPC).](https://jamanetwork.com/journals/jamanetworkopen/article-abstract/2809637) *JAMA Network Open*, **6**(9), e2334208.

3. Graham, L., Henderson, N.C., Kellezi, O., ..., and M.T. Schweizer (2024). [DNA Damaging Therapies in Patients with Prostate Cancer and Pathogenic Alterations in Homologous Recombination Repair Genes.](https://ascopubs.org/doi/full/10.1200/PO.24.00014) *JCO Precision Oncology*, **8**, e2400014.


## Urothelial Cancer

1. Koshkin, V.S., Henderson, N.C., James, M., ...., and A. Alva (2022). [Efficacy of enfortumab vedotin in advanced urothelial cancer: analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) registry.](https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.34057)
*Cancer*, **128**(6), 1194-1205.


## Breast Cancer

1. Rutherford, D.V., Medley, S., Henderson, N.C., 
Gersch, C.L.,..., and D.L. Hertz (2023). [Effects of CYP3A4 and CYP2C9 genotype on systemic anastrozole and fulvestrant concentrations in SWOG S0226.](https://www.futuremedicine.com/doi/abs/10.2217/pgs-2023-0097) *Pharmacogenomics*, **24**(12), 665-673.

## Drug Sensitivity Prediction

1. Costello et al. (2014). [A community effort to assess and improve drug sensitivity prediction algorithms](https://www.nature.com/articles/nbt.2877) *Nature Biotechnology*, **32**, 1202â€“1212.


<!--{% include base_path %}

{% for post in site.publications reversed %}
  {% include archive-single.html %}
{% endfor %}-->
